Article
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment.
BMC pulmonary medicine - 23 May 2016
Cernomaz Andrei-Tudor, Macovei Ina Iuliana, Pavel Ionut, Grigoriu Carmen, Marinca Mihai, Baty Florent, Peter Simona, Zonda Radu, Brutsche Martin, Grigoriu Bogdan- Dragos
Abstract excerpt
BACKGROUND: The epidermal growth factor receptor (EGFR) mutation status assessment has become increasingly important given the significant impact of tyrosine kinase inhibitors in lung cancer management. Our aim was to compare real life operational characteristics for three EGFR mutation assays - two targeted approaches and a next generation sequencing (NGS) technique. METHODS: EGFR mutation status was assessed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
